Last Price
0.04
Today's Change
0.00 (0.00%)
Day's Change
0.038 - 0.042
Trading Volume
1,642,378
Market Cap
29 Million
Shares Outstanding
748 Million
Avg Volume
2,025,222
Avg Price (50 Days)
0.03
Avg Price (200 Days)
0.04
PE Ratio
-1.33
EPS
-0.03
Earnings Announcement
24-Feb-2025
Previous Close
0.04
Open
0.04
Day's Range
0.038 - 0.042
Year Range
0.028 - 0.092
Trading Volume
1,709,028
1 Day Change
0.00%
5 Day Change
8.11%
1 Month Change
8.11%
3 Month Change
-9.09%
6 Month Change
-5.27%
Ytd Change
5.26%
1 Year Change
-54.02%
3 Year Change
-95.66%
5 Year Change
-96.46%
10 Year Change
-96.46%
Max Change
-96.46%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.